
ELV last traded at $353.91, within a 52-week range of $273.71 (low) and $458.75 (high), according to chart/DMA data sourced from TechnicalAnalysisChannel.com. The note provides only price-range technical context and a pointer to related holdings links, with no fundamental results, guidance, or new material catalysts likely to alter valuations.
Market structure: ELV (Elevance Health) sits mid‑range (last 353.91; 52‑week low 273.71, high 458.75) which signals a market balancing between defensive insurer demand and growth skepticism. Winners are Medicare Advantage–heavy payers (ELV, HUM, UNH) if enrollment and risk scores hold; losers are providers and high-cost PBMs if managed‑care tightness accelerates. Cross‑asset: a 100bp move in 10y rates changes insurer discounting materially (rough guide: 3–7% fair‑value swing), which propagates into equity beta, option IV (likely muted), and bond spreads for insurer debt.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment